Analysis of correlation between 3 single nucleotide polymorphisms of catechol-O-methyltransferase gene and therapeutic effect of risperidone in first-episode schizophrenics

Lu-xian L(U),Mei-zhi JIA,Wen-qiang LI
DOI: https://doi.org/10.3321/j.issn:1006-7884.2008.01.004
2008-01-01
Abstract:Objective To analyze the correlation between therapeutic effect of antipsychotic agent risperidone and catechol-O-methyltransferase(COMT)gene polymorphisms in first-episode schizophrenics,to further study the mechanisms of psychiatric symptoms,and to identify genes sensitive to risperidone medication.Methods 203 first-episode schizophrenics were treated with risperidone(2~8 ms/day)for 8 weeks. Reduction rate in PANSS total score from baseline to week 8 Was used for efiectiveness evaluation.Patients were divided into 3 groups based on reduction rate of PANSS total score,i.e.,remitted (≥75%,n=29),improved(75%~25%,n=153)and unresponsive(≤25%,n=21).Restriction fragment length polymorphism analysis as well as sequence-special primers PCR amplification technique were used to determine the genotypes.Results There Was on statistically significant difference in the 3 COMT polymorphism genotypes as well as allele frequency between the 3 schizophrenic groups with different responsiveness to risperidone(P>0.05).Haplotype analysis of the 3 COMT single nucleotide polymorphisms showed no statistically significant difference among remitted group,improved group and unresponsive group.Condusions COMT gene is unlikely a sensitive gene determining the therapeutic effect of antipsychotic agent risperidone in schizophrenia.
What problem does this paper attempt to address?